What You Should Know:
- H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution.
- Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More
H1
22 Executive Digital Health Predictions to Watch in 2023
Jon Bloom, MD, CEO and Co-founder of Podimetrics
From a digital health perspective, 2022 was a reset year for many and a serious reality check. We went from sky high growth to the sky is falling, and in 2023 I think this market correction movement will continue forward. To me, the biggest surprise of 2022 was that despite the market tanking, digital health companies continued to truck forward with huge deals. This includes massive acquisitions like Amazon and OneMedical, as well as deals like
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
20 Executives Share Health IT Predictions to Watch in 2023
We asked several healthcare executives to share their health IT predictions and trends for 2023.
Nate Maslak, the co-founder/CEO of Ribbon Health
Data Personalization: 38% of consumers want more personalized and inclusive healthcare options. In 2023, we’ll see a greater shift towards healthcare enterprises prioritizing this personalization, by innovating their current data infrastructure to show a range of information that lets a patient make an educated care decision based on what
Read More
2022 Healthcare Investment, M&A, IPO Market Trends/Insights
What You Should Know:
- The latest edition of SVB's Healthcare Investments and Exits report provides information on VC fundraising, investments and M&A and IPO trends - along with subsector analysis and video commentary for each.
- Healthcare trends indicate US healthcare VC investment was healthy in 2022 despite an economic downturn. There's plenty of dry powder to deploy; however, investments and exits are slowing due to the volatile market.
Trends and Insights – Healthcare
Read More
How AI-Based Drug Repurposing Could Help Prevent Repetitive Behavior Disorders
Repetitive behavioral disorders such as obsessive-compulsive disorder (OCD), Tic Disorder and Tourette Syndrome have been challenging to treat because they involve considerable complexity. For example, the symptoms of one disorder can vary among individuals as does the coexistence or non-existence of other behavior disorders such as anxiety and depression. Further, the treatment of OCD, Tic Disorder and Tourette Syndrome varies depending on
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
H1 & Lokavant Partner to Power Next-Gen Clinical Trials
What You Should Know:
- H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development
- As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.
Integrating Clinical Trial Data Sources to Intelligence Platforms
Lokavant is a clinical
Read More
Can We Reach Health 4.0 in the Next 3-5 Years?
What You Should Know:
- According to a new report from Allison + Partners, 57% of respondents said it will be possible to achieve “Health 4.0” in the next 3-5 years
- The report illustrates that the biggest hurdles include legislative and regulatory policy, lack of tech talent, and little understanding of health technologies and that the opportunities outweigh the challenges
Health 4.0: Barriers and Solutions
During the pandemic, there was a record-breaking infusion of capital into
Read More
H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data
What You Should Know:
- H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M.
- The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More
